Search Results - Patrick Y. Wen

Refine Results
  1. 1
    Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice

    Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice by Ugonma Chukwueke, Patrick Y. Wen

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Therapeutic Advances in the Treatment of Glioblastoma: Rationale and Potential Role of Targeted Agents

    Therapeutic Advances in the Treatment of Glioblastoma: Rationale and Potential Role of Targeted Agents by David A. Reardon, Patrick Y. Wen

    Published 2006
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Gender and sex disparity in cancer trials

    Gender and sex disparity in cancer trials by Eudocia Q. Lee, Patrick Y. Wen

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications

    The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications by Patrick Y. Wen, Roger J. Packer

    Published 2021
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  5. 5
    Imaging in neuro-oncology

    Imaging in neuro-oncology by Hari Nandu, Patrick Y. Wen, Raymond Y. Huang

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Epidemiology of brain metastases and leptomeningeal disease

    Epidemiology of brain metastases and leptomeningeal disease by Nayan Lamba, Patrick Y. Wen, Ayal A. Aizer

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials

    Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials by Benjamin M. Ellingson, Patrick Y. Wen, Timothy F. Cloughesy

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma

    Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma by Benjamin M. Ellingson, Patrick Y. Wen, Timothy F. Cloughesy

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors

    Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors by Terri S. Armstrong, Patrick Y Wen, Mark R. Gilbert, David Schiff

    Published 2012
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies

    Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies by Kathryn Field, Justin T. Jordan, Patrick Y. Wen, Mark Rosenthal, David A. Reardon

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response

    Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response by Raymond Y. Huang, Martha R. Neagu, David A. Reardon, Patrick Y. Wen

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Response criteria for glioma

    Response criteria for glioma by A. Gregory Sorensen, Tracy T. Batchelor, Patrick Y. Wen, Weiting Zhang, Rakesh K. Jain

    Published 2008
    Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy

    Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy by David A. Reardon, Patrick Y. Wen, Annick Desjardins, Tracy T. Batchelor, James J. Vredenburgh

    Published 2008
    Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Graft-Versus-Host Disease of the CNS After Allogeneic Bone Marrow Transplantation

    Graft-Versus-Host Disease of the CNS After Allogeneic Bone Marrow Transplantation by Ali G. Saad, Edwin P. Alyea, Patrick Y. Wen, Umberto DeGirolami, Santosh Kesari

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Pros and cons of current brain tumor imaging

    Pros and cons of current brain tumor imaging by Benjamin M. Ellingson, Patrick Y. Wen, Martin J. van den Bent, Timothy F. Cloughesy

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients

    Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients by Minesh P. Mehta, Patrick Y. Wen, Ryo Nishikawa, David A. Reardon, Katherine B. Peters

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma

    A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma by Isabel Arrillaga‐Romany, S. Andrew, Joshua E. Allen, Wolfgang Oster, Patrick Y. Wen, Tracy T. Batchelor

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    RANO 2.0: The revised Response Assessment in Neuro-Oncology (RANO) criteria for high- and low-grade glial tumors in adults designed for the future

    RANO 2.0: The revised Response Assessment in Neuro-Oncology (RANO) criteria for high- and low-grade glial tumors in adults designed for the future by Patrick Y. Wen, Martin J. van den Bent, Michael A. Vogelbaum, Susan M. Chang

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Current clinical development of PI3K pathway inhibitors in glioblastoma

    Current clinical development of PI3K pathway inhibitors in glioblastoma by Patrick Y. Wen, E. Q. Lee, David A. Reardon, Keith L. Ligon, W.K. Alfred Yung

    Published 2012
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib

    Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib by Elizabeth R. Gerstner, Poe-Jou Chen, Patrick Y. Wen, Rakesh K. Jain, Tracy T. Batchelor, Gregory Sorensen

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: